Assignee
SCINNOHUB PHARMACEUTICAL CO LTD
CN·1 granted patent·9 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
10 records- 0163US2025325526A1Use of tetrahydronaphthyridine derivative for preparing product for improving hyperpigmentationSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0256US2026001892A1Compound for regulating and controlling activity of 15-pgdh and preparation method thereforSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0354US2025250283A1Compound capable of regulating and controlling activity of 15-pgdh, and preparation method thereforSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0452US2025154162A1Compound for regulating and controlling 15-pgdh activity and preparation method thereforSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0549US2025145635A1Compound containing bis(azanylylidene) sulfonyl structure and use thereof in medicineSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0649US2024300986A1Plasmin inhibitor, preparation method therefor and application thereofSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0748US2024124443A1Plasmin inhibitor, preparation method therefor, and application thereofSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0847US2024228491A1Methionine adenosyltransferase inhibitor, preparation method therefor and application thereofSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0944US12428433B2Fluorine-containing heterocyclic derivatives with macrocyclic structure and use thereofSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2020·Granted Sep 30, 2025·0 cites·4 claims
- 1042US2023219978A1Compound having macrocyclic structure and use thereofSCINNOHUB PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SCINNOHUB PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →